Terug
67
Dagbereik
€ 17,01
€ 17,77
52-Weeksbereik
€ 11,63
€ 23,87
Volume
2.293.661
50D / 200D Gem.
€ 20,42
/
€ 17,32
Vorige Slotkoers
€ 17,51
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4915,5 | 0,3 |
| P/B | 19,9 | 2,9 |
| ROE % | -0,5 | 3,7 |
| Net Margin % | 0,0 | 3,8 |
| Rev Growth 5Y % | 35,6 | 10,0 |
| D/E | 1,9 | 0,2 |
Koersdoel Analisten
Hold
€ 24,50
+40.6%
Low: € 18,00
High: € 30,00
Forward K/W
133,2
Forward WPA
€ 0,13
WPA Groei (sch.)
+0,0%
Omzet Sch.
5,2 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,71
€ 1,64 – € 1,80
|
14 B | 1 |
| FY2029 |
€ 1,29
€ 1,24 – € 1,36
|
11 B | 1 |
| FY2028 |
€ 0,73
€ 0,52 – € 0,86
|
8 B | 5 |
Belangrijkste Punten
Revenue grew 35,60% annually over 5 years — strong growth
Generating 113,15M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10,46%
Capital efficient — spends only 0,68% of revenue on capex
ROIC of 2,14% — low return on invested capital
Interest coverage of 0,93× — tight debt servicing
Groei
Revenue Growth (5Y)
35,60%
Revenue (1Y)46,06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-0,52%
ROIC2,14%
Net Margin-0,02%
Op. Margin0,37%
Veiligheid
Debt / Equity
1,89
Current Ratio1,74
Interest Coverage0,93
Waardering
P/E Ratio
-4915,53
P/B Ratio19,85
EV/EBITDA224,98
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 46,06% | Revenue Growth (3Y) | 47,15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 35,60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,95B | Net Income (TTM) | -724.000,0 |
| ROE | -0,52% | ROA | -0,07% |
| Gross Margin | 12,37% | Operating Margin | 0,37% |
| Net Margin | -0,02% | Free Cash Flow (TTM) | 113,15M |
| ROIC | 2,14% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,89 | Current Ratio | 1,74 |
| Interest Coverage | 0,93 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4915,53 | P/B Ratio | 19,85 |
| P/S Ratio | 0,90 | PEG Ratio | 54,31 |
| EV/EBITDA | 224,98 | Dividend Yield | 0,00% |
| Market Cap | 3,56B | Enterprise Value | 3,32B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,95B | 2,70B | 1,82B | 1,43B | 1,17B |
| Net Income | -724.000,0 | -128,04M | -148,02M | -149,55M | -195,29M |
| EPS (Diluted) | 0,00 | -0,67 | -0,79 | -0,83 | -1,14 |
| Gross Profit | 488,56M | 296,69M | 201,03M | 184,28M | 128,73M |
| Operating Income | 14,75M | -101,56M | -127,82M | -128,64M | -178,07M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,07B | 782,06M | 591,88M | 633,86M | 630,90M |
| Total Liabilities | 886,51M | 681,11M | 433,81M | 394,56M | 324,84M |
| Shareholders' Equity | 179,28M | 99,85M | 156,95M | 238,13M | 306,04M |
| Total Debt | 338,07M | 329,26M | 170,79M | 164,60M | 157,60M |
| Cash & Equivalents | 577,94M | 432,86M | 202,90M | 409,55M | 466,60M |
| Current Assets | 831,14M | 661,64M | 483,54M | 544,55M | 552,86M |
| Current Liabilities | 476,53M | 351,85M | 263,02M | 229,96M | 167,25M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#87 of 618
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026